K Sorsdahl1, D J Stein2,3, S Pasche4, Y Jacobs5,6, R Kader2, B Odlaug7, S Richter8, B Myers2,6, J E Grant9. 1. Alan J. Flisher Centre for Public Mental Health, Department of Psychiatry & Mental Health, University of Cape Town, 46 Sawkins Rd., Cape Town, 7700, South Africa. Katherine.sorsdahl@uct.ac.za. 2. Department of Psychiatry & Mental Health, University of Cape Town, Cape Town, South Africa. 3. South African Medical Research Council Unit on Risk & Resilience in Mental Disorders, Cape Town, South Africa. 4. Department of Psychology, Stellenbosch University, Stellenbosch, South Africa. 5. Alan J. Flisher Centre for Public Mental Health, Department of Psychiatry & Mental Health, University of Cape Town, 46 Sawkins Rd., Cape Town, 7700, South Africa. 6. Alcohol, Tobacco and Other Drug Research Unit, South African Medical Research Council, Cape Town, South Africa. 7. Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN, USA. 8. Professional Data Analysts, Minneapolis, United States. 9. Department of Psychiatry & Behavioural Neuroscience, University of Chicago, Chicago, United States.
Abstract
BACKGROUND: Effective brief treatments for methamphetamine use disorders (MAUD) are urgently needed to complement longer more intensive treatments in low and middle income countries, including South Africa. To address this gap, the purpose of this randomised feasibility trial was to determine the feasibility of delivering a six-session blended imaginal desensitisation, plus motivational interviewing (IDMI) intervention for adults with a MAUD. METHODS: We enrolled 60 adults with a MAUD and randomly assigned them 1:1 to the IDMI intervention delivered by clinical psychologists and a control group who we referred to usual care. Feasibility measures, such as rates of recruitment, consent to participate in the trial and retention, were calculated. Follow-up interviews were conducted at 6 weeks and 3 months post-enrollment. RESULTS: Over 9 months, 278 potential particiants initiated contact. Following initial screening 78 (28%) met inclusion criteria, and 60 (77%) were randomised. Thirteen of the 30 participants assigned to the treatment group completed the intervention. Both psychologists were highly adherent to the intervention, obtaining a fidelity rating of 91%. In total, 39 (65%) participants completed the 6-week follow-up and 40 (67%) completed the 3-month follow-up. The intervention shows potential effectiveness in the intention-to-treat analysis where frequency of methamphetamine use was significantly lower in the treatment than in the control group at both the 6 week and 3-month endpoints. No adverse outcomes were reported. CONCLUSIONS: This feasibility trial suggests that the locally adapted IDMI intervention is an acceptable and safe intervention as a brief treatment for MAUD in South Africa. Modifications to the study design should be considered in a fully powered, definitive controlled trial to assess this potentially effective intervention. Trial registration The trial is registered with the Pan African Clinical Trials Registry (Trial ID: PACTR201310000589295).
RCT Entities:
BACKGROUND: Effective brief treatments for methamphetamine use disorders (MAUD) are urgently needed to complement longer more intensive treatments in low and middle income countries, including South Africa. To address this gap, the purpose of this randomised feasibility trial was to determine the feasibility of delivering a six-session blended imaginal desensitisation, plus motivational interviewing (IDMI) intervention for adults with a MAUD. METHODS: We enrolled 60 adults with a MAUD and randomly assigned them 1:1 to the IDMI intervention delivered by clinical psychologists and a control group who we referred to usual care. Feasibility measures, such as rates of recruitment, consent to participate in the trial and retention, were calculated. Follow-up interviews were conducted at 6 weeks and 3 months post-enrollment. RESULTS: Over 9 months, 278 potential particiants initiated contact. Following initial screening 78 (28%) met inclusion criteria, and 60 (77%) were randomised. Thirteen of the 30 participants assigned to the treatment group completed the intervention. Both psychologists were highly adherent to the intervention, obtaining a fidelity rating of 91%. In total, 39 (65%) participants completed the 6-week follow-up and 40 (67%) completed the 3-month follow-up. The intervention shows potential effectiveness in the intention-to-treat analysis where frequency of methamphetamine use was significantly lower in the treatment than in the control group at both the 6 week and 3-month endpoints. No adverse outcomes were reported. CONCLUSIONS: This feasibility trial suggests that the locally adapted IDMI intervention is an acceptable and safe intervention as a brief treatment for MAUD in South Africa. Modifications to the study design should be considered in a fully powered, definitive controlled trial to assess this potentially effective intervention. Trial registration The trial is registered with the Pan African Clinical Trials Registry (Trial ID: PACTR201310000589295).
Entities:
Keywords:
Brief treatment; Feasibility trial; South Africa; Substance use
Authors: Dan J Stein; Soraya Seedat; Allen Herman; Hashim Moomal; Steven G Heeringa; Ronald C Kessler; David R Williams Journal: Br J Psychiatry Date: 2008-02 Impact factor: 9.319
Authors: Christina S Meade; Sheri L Towe; Melissa H Watt; Andrea L Hobkirk; Donald Skinner; Bronwyn Myers; Stephen M Kimani; Desiree Pieterse Journal: AIDS Behav Date: 2015-01
Authors: Jon E Grant; Christopher B Donahue; Brian L Odlaug; Suck Won Kim; Michael J Miller; Nancy M Petry Journal: Br J Psychiatry Date: 2009-09 Impact factor: 9.319
Authors: Andreas Plüddemann; Alan J Flisher; Rebecca McKetin; Charles Parry; Carl Lombard Journal: Drug Alcohol Depend Date: 2010-01-12 Impact factor: 4.492
Authors: Wendee M Wechsberg; Rachel Jewkes; Scott P Novak; Tracy Kline; Bronwyn Myers; Felicia A Browne; Tara Carney; Antonio A Morgan Lopez; Charles Parry Journal: BMJ Open Date: 2013-05-28 Impact factor: 2.692
Authors: Wendee M Wechsberg; Isa van der Drift; Brittni N Howard; Bronwyn Myers; Felicia A Browne; Courtney Peasant Bonner; Tara Carney; Jacqueline Ndirangu; Yukiko Washio Journal: Int J Environ Res Public Health Date: 2022-07-16 Impact factor: 4.614